Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare Cagrilintide is a long acting amylin analog that regulates appetite, gastric emptying, and glucagon secretion to treat obesity and related metabolic disorders. There are 2 pathways cagrilintide works: #1 is the Amylin pathway In Chinese adults with overweight or obesity, once weekly #GLP glucagon agonist mazdutide, at a dose of 4 mg or 6 mg for 32 48 weeks, led to clinically relevant #weightloss in the Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes Forst 2025 Diabetes, Obesity and Metabolism Wiley Online Library Mazdutide Bulk Supply buy from factory 99% Purity powder Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants Gabe 2024 Diabetes, Obesity and Metabolism Wiley Online Library